8 completed, 7 terminated, 4 active not recruiting, 3 unknown. 6 Not applicable, 4 Early Phase 1, 3 Phase 2, 2 Phase 1.
Follow Dynamic Contrast Enhanced Magnetic Resonance Imaging: new trials by email Literature Review of Dynamic Contrast Enhanced Magnetic Resonance Imaging trials Research Report on Dynamic Contrast Enhanced Magnetic Resonance Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease DCE MRI - Peripheral Arterial Disease, Perfusion | Unknown | Fudan University | 30 | 2024-08-01 | 2024-07-29 | |
| New MRI Techniques for Diagnosis and Treatment of Patients With Abdominal Aortic Aneurysms Magnetic resonance imaging (with PROUD software) - Abdominal Aortic Aneurysm Without Rupture | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 66 | 2023-05-04 | 2025-07-15 | |
| Bayer OA Knee Pain Pilot dynamic contrast enhanced MRI, geniculate artery embolization - Osteoarthritis, Knee | Not applicable | Active not recruiting | Medical University of South Carolina | 12 | 2022-10-01 | 2026-07-22 |
| StrokeCog-BBB to Study Cognitive Outcomes Following Stroke DCE-MRI - Stroke | Recruiting | Stanford University | 350 | 2022-05-17 | 2024-04-18 | |
| Comparison of Three Methods for Early Detection of Breast Cancer Contrast Enhanced imaging, Lumason - Proliferative Breast Disease | Early Phase 1 | Completed | Mayo Clinic | 3 | 2019-10-15 | 2022-01-10 |
| Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer Concurrent Chemoradiotherapy, Dynamic Contrast-Enhanced MRI Perfusion (DCE-MRI) - Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal HPV Squamous Cell Carcinoma | Not applicable | Active not recruiting | Institute of Oncology Ljubljana | 30 | 2019-06-10 | 2026-02-17 |
| Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma Monoclonal antibody, Bevacizumab, Blood sample - Glioblastoma | Phase 1 | Unknown | Assistance Publique Hopitaux De Marseille | 34 | 2019-01-01 | 2018-08-17 |
| Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer MRI, PET-CT, Endoscopy - Esophageal Cancer, Esophageal Adenocarcinoma | Unknown | UMC Utrecht | 200 | 2018-04-09 | 2020-11-16 | |
| Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma? Dynamic contrast-enhanced MRI - Retinoblastoma | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 60 | 2018-01-11 | 2026-01-05 | |
| In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI Diagnostic (ferumoxytol-enhanced MRI), Surgery, Ferumoxytol - Childhood Brain Neoplasm | Early Phase 1 | Withdrawn | Michael Iv | 2017-07-01 | 2023-04-14 | |
| QSM and Regional DCE MRI Permeability Using GOCART Technique Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Gadobenate Dimeglumine, Gadoterate Meglumine - Intracranial Neoplasm | Withdrawn | University of Southern California | 2017-04-04 | 2021-04-05 | ||
| Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment - Asymptomatic | Not applicable | Active not recruiting | ECOG-ACRIN Cancer Research Group | 1516 | 2016-12-27 | 2026-02-25 |
| Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors MRI-guided laser ablation, Doxorubicin, Etoposide - Glioma, Pilocytic Astrocytoma | Phase 2 | Terminated | Washington University School of Medicine | 6 | 2015-08-14 | 2024-11-01 |
| Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy multi-parametric MRI(MP-MRI), dynamic contrast-enhanced MRI (DCE), biopsy - Prostate Cancer | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 120 | 2014-12-01 | 2026-01-29 |
| Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection PEGPH20, Cetuximab, DW & DCE-MRI - Pancreatic Cancer | Not applicable | Completed | Memorial Sloan Kettering Cancer Center | 2 | 2014-09-12 | 2017-09-27 |
| PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer MRI and PET-CT - Esophageal Cancer | Completed | Gert Meijer | 30 | 2013-10-01 | 2020-11-16 | |
| Evaluation of Patients With Knee Osteoarthritis Receiving a Prosthesis Clinical evaluation, Radiology, Dynamic contrast-enhanced magnetic resonance imaging - Osteoarthritis, Knee, Perfusion | Completed | Lille Catholic University | 22 | 2013-05-01 | 2018-08-23 | |
| Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads Perflutren Lipid Microspheres, Dynamic Contrast-Enhanced Ultrasound Imaging, Contrast-enhanced Magnetic Resonance Imaging - Hepatocellular Carcinoma | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 15 | 2012-12-12 | 2025-05-02 |
| 3T MRI Biomarkers of Glioma Treatment Response 3-Tesla magnetic resonance imaging, CEST-MRI, DW-MRI - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Early Phase 1 | Terminated | Vanderbilt-Ingram Cancer Center | 7 | 2012-05-01 | 2017-04-17 |
| FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer fludeoxyglucose F 18, positron emission tomography, dynamic contrast-enhanced magnetic resonance imaging - Male Breast Cancer, Stage II Breast Cancer | Not applicable | Terminated | University of Washington | 35 | 2011-11-01 | 2023-11-18 |
Showing 20 of 26. Sign in to see all of them.
Glioblastoma (5) · Astrocytoma (3) · Brain Neoplasms (2) · Esophageal Neoplasms (2) · Glioma (2) · Neoplasm Metastasis (2) · Oligodendroglioma (2) · Osteoarthritis, Knee (2) · Adenocarcinoma Of Esophagus (1) · Aortic Aneurysm, Abdominal (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Carcinoma, Squamous Cell (1)
Memorial Sloan Kettering Cancer Center (2) · Abramson Cancer Center at Penn Medicine (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · American College of Radiology (1) · Assistance Publique Hopitaux De Marseille (1) · ECOG-ACRIN Cancer Research Group (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · Fudan University (1) · Gert Meijer (1) · Haukeland University Hospital (1) · Institute of Oncology Ljubljana (1) · Lille Catholic University (1) · Mayo Clinic (1) · Medical University of South Carolina (1) · Michael Iv (1)
United States (15) · France (3) · Netherlands (3) · Germany (1) · Norway (1) · Slovenia (1)
Gert J Meijer, PhD (2) · Alexander Lerner (1) · Andre Uflacker, MD (1) · Andrew Cluster, M.D. (1) · Augustin Lecler, MD (1) · Chad Quarles (1) · Christopher Comstock (1) · Donald Mitchell, MD (1) · Flemming Forsberg, PhD (1) · Hanneke WM van Laarhoven, MD, PhD (1) · Hans Petter Eikesdal, MD PhD (1) · Jelle P Ruurda, MD, PhD (1) · Jennifer Specht (1)
PMID 30342494, PMID 31221527, PMID 32096852, PMID 37946201, PMID 42392285, PMID 42629616
P30CA014089 (1), P30CA015704 (1), P30CA068485 (1), P30CA124435 (1), P50CA138293 (1), UG1CA189828 (1)